Diaphragm Ultrasound to Evaluate the Antagonistic Effect of Sugammadex
Diaphragm Ultrasound to Evaluate the Antagonistic Effect of Sugammadex on Rocuronium After Liver Surgery in Patients With Different Liver Child-Pugh Grades
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
A PHASE4 clinical study on Diaphragm Ultrasonography and Liver Dysfunction, this trial is ongoing. The trial is conducted by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology and has accumulated 7 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE4
-
Aug 2025 — Sep 2025 [monthly]
Unknown PHASE4
-
Sep 2024 — Aug 2025 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Sep 2023 — Jul 2024 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Oct 2021 — Sep 2023 [monthly]
Recruiting PHASE4
-
Sep 2021 — Oct 2021 [monthly]
Recruiting PHASE4
First recorded
Jul 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
For direct contact, visit the study record on ClinicalTrials.gov .